BioSpace News Archive

Pharm Country

HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 44th ANNUAL GLOBAL HEALTHCARE CONFERENCE

Harmony Biosciences Holdings, Inc. today announced that Harmony’s management team will participate in a fireside chat at the upcoming Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA on Tuesday, June 13, 2023, at 2:00 p.m. PT/ 5:00 p.m. ET.

May 30, 2023
·
1 min read
Biotech Bay

Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023

Personalis, Inc. (Nasdaq: PSNL) today announced it will present new clinical data as scientific posters at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023, which convenes from June 2-6, 2023, in Chicago, Ill.

May 30, 2023
·
6 min read
Pharm Country

Acorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&A - May 30, 2023

Acorda Therapeutics, Inc. (Nasdaq: ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Wednesday, June 7 at 1:00pm ET, 10:00am PT.

May 30, 2023
·
5 min read
Business

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - May 30, 2023

Morphogenesis, Inc. and CohBar, Inc. today announced that Morphogenesis’ abstract has been accepted for poster presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

May 30, 2023
·
10 min read
Genetown

Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting

Moderna, Inc. today announced that two abstracts on mRNA-4157 (V940), an investigational mRNA individualized neoantigen therapy, have been accepted for presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting being held June 2-6 in Chicago, IL.

May 30, 2023
·
5 min read
Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute

Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute.

May 30, 2023
·
3 min read
Pharm Country

Ceramedix Joins Johnson & Johnson Innovation - JLABS as a Resident Company

Ceramedix, Inc. announced it has joined Johnson & Johnson Innovation – JLABS as a resident company.

May 30, 2023
·
2 min read
BioMidwest

SAB Biotherapeutics to Present Novel Human IgG Platform with Positive Data and Breakthrough Therapy and Fast-Track Designations for Influenza Treatment at BIO 2023 International Convention

SAB Biotherapeutics announced that Eddie J. Sullivan, Ph.D., co-founder, President and Chief Executive Officer of SAB Biotherapeutics will present at the BIO 2023 International Convention.

May 30, 2023
·
5 min read
Pharm Country

Cormedix Inc. To Present At The Jefferies Healthcare Conference

CorMedix Inc. today announced that management will be presenting and participating in investor meetings at the Jefferies Healthcare Conference being held in New York on June 7 – 9, 2023.

May 30, 2023
·
2 min read
Drug Development

Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced dosing of the first subject in the Phase 1 trial of PYX-106.

May 30, 2023
·
9 min read